Siegfried Holding AG (0QQO.L)

CHF 978.56

(0.57%)

Revenue Summary of Siegfried Holding AG

  • Siegfried Holding AG's latest annual revenue in 2023 was 1.27 Billion CHF , up 3.41% from previous year.
  • Siegfried Holding AG's latest quarterly revenue in 2024 Q2 was 619.9 Million CHF , down 0.0% from previous quarter.
  • Siegfried Holding AG reported a annual revenue of 1.22 Billion CHF in annual revenue 2022, up 11.53% from previous year.
  • Siegfried Holding AG reported a annual revenue of 1.1 Billion CHF in annual revenue 2021, up 30.45% from previous year.
  • Siegfried Holding AG reported a quarterly revenue of 607.05 Million CHF for 2023 Q2, down 0.0% from previous quarter.
  • Siegfried Holding AG reported a quarterly revenue of 1.27 Billion CHF for 2023 FY, up 3.41% from previous quarter.

Annual Revenue Chart of Siegfried Holding AG (2023 - 2002)

Historical Annual Revenue of Siegfried Holding AG (2023 - 2002)

Year Revenue Revenue Growth
2023 1.27 Billion CHF 3.41%
2022 1.22 Billion CHF 11.53%
2021 1.1 Billion CHF 30.45%
2020 845.06 Million CHF 1.39%
2019 833.51 Million CHF 4.94%
2018 794.29 Million CHF 5.84%
2017 750.46 Million CHF 4.56%
2016 717.72 Million CHF 49.35%
2015 480.57 Million CHF 52.43%
2014 315.28 Million CHF -15.91%
2013 374.94 Million CHF 1.94%
2012 367.8 Million CHF 12.1%
2011 328.09 Million CHF 4.35%
2010 314.4 Million CHF 11.08%
2009 283.04 Million CHF -1.98%
2008 288.74 Million CHF -9.27%
2007 318.25 Million CHF 6.17%
2006 299.76 Million CHF -5.83%
2005 318.33 Million CHF -0.94%
2004 321.36 Million CHF -12.26%
2003 366.26 Million CHF -8.22%
2002 399.05 Million CHF 0.0%

Peer Revenue Comparison of Siegfried Holding AG

Name Revenue Revenue Difference
Relief Therapeutics Holding AG 6.03 Million CHF -20975.651%
Tecan Group AG 1.07 Billion CHF -18.346%
Santhera Pharmaceuticals Holding AG 103.41 Million CHF -1129.518%
Basilea Pharmaceutica AG 157.63 Million CHF -706.612%
Bachem Holding AG 577.31 Million CHF -120.242%
Molecular Partners AG 7.03 Million CHF -17966.127%